Cargando…

Factors Associated with Inadequate Intravenous Colistin Dosages: Post Hoc Analysis of a Multicenter, Cross-Sectional Study

Colistin is a last-resort agent for the treatment of infections due to Gram-negative bacteria with difficult-to-treat resistance. The primary objective of this post hoc analysis of a cross-sectional study conducted in 22 Italian hospitals was to assess factors associated with inadequate intravenous...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giacobbe, Daniele Roberto, Mirabella, Michele, Rinaldi, Matteo, Losito, Angela Raffaella, Raffaelli, Francesca, Del Puente, Filippo, Saffioti, Carolina, Mikulska, Malgorzata, Giannella, Maddalena, Viale, Pierluigi, Tumbarello, Mario, Bassetti, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8698974/ https://www.ncbi.nlm.nih.gov/pubmed/34943767 http://dx.doi.org/10.3390/antibiotics10121554

Ejemplares similares

XDR-Pseudomonas aeruginosa Outside the ICU: Is There Still Place for Colistin?
por: Del Giacomo, Paola, et al.
Publicado: (2022)

Pharmacokinetic/Pharmacodynamic Analysis of Continuous-Infusion Fosfomycin in Combination with Extended-Infusion Cefiderocol or Continuous-Infusion Ceftazidime-Avibactam in a Case Series of Difficult-to-Treat Resistant Pseudomonas aeruginosa Bloodstream Infections and/or Hospital-Acquired Pneumonia
por: Gatti, Milo, et al.
Publicado: (2022)

Risk Factors for Candidemia After Open Heart Surgery: Results From a Multicenter Case–Control Study
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

New Drugs for the Treatment of Pseudomonas aeruginosa Infections with Limited Treatment Options: A Narrative Review
por: Losito, Angela Raffaella, et al.
Publicado: (2022)

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2020)

214. The impact of preservation fluid culture on graft site arteritis: a systematic review and metanalysis.
por: Rinaldi, Matteo, et al.
Publicado: (2022)

The impact of preservation fluid culture on graft site arteritis: A systematic review and meta‐analysis
por: Rinaldi, Matteo, et al.
Publicado: (2022)

Successful Treatment of Bacteremia and Ventilator-Associated Pneumonia Caused by KPC/OXA-48-like Klebsiella pneumoniae Co-Producer with a Continuous Infusion of High-Dose Meropenem Plus Fosfomycin Guided by Real-Time Therapeutic Drug Monitoring
por: Cojutti, Pier Giorgio, et al.
Publicado: (2022)

Ceftolozane/Tazobactam for Treatment of Severe ESBL-Producing Enterobacterales Infections: A Multicenter Nationwide Clinical Experience (CEFTABUSE II Study)
por: Bassetti, Matteo, et al.
Publicado: (2020)

Optimal control for colistin dosage selection
por: Gontijo, Aline Vidal Lacerda, et al.
Publicado: (2021)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022)

Impact of Maximizing Css/MIC Ratio on Efficacy of Continuous Infusion Meropenem Against Documented Gram-Negative Infections in Critically Ill Patients and Population Pharmacokinetic/Pharmacodynamic Analysis to Support Treatment Optimization
por: Cojutti, Pier Giorgio, et al.
Publicado: (2021)

Compassionate use of meropenem/vaborbactam for infections caused by KPC-producing Klebsiella pneumoniae: a multicentre study
por: Tumbarello, Mario, et al.
Publicado: (2022)

Opportunistic infections in end stage liver disease
por: Bartoletti, Michele, et al.
Publicado: (2018)

A new call for influenza and pneumococcal vaccinations during COVID-19 pandemic in Italy: A SIP/IRS (Italian Respiratory Society) and SITA (Italian Society of Antiinfective therapy) statement
por: Blasi, Francesco, et al.
Publicado: (2021)

Breakthrough invasive fungal infections in liver transplant recipients exposed to prophylaxis with echinocandins vs other antifungal agents: A systematic review and meta‐analysis
por: Gatti, Milo, et al.
Publicado: (2021)

Non-fermentative gram-negative bloodstream infection in northern Italy: a multicenter cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Efficacy and Safety of Meropenem–Vaborbactam Versus Best Available Therapy for the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in Patients Without Prior Antimicrobial Failure: A Post Hoc Analysis
por: Bassetti, Matteo, et al.
Publicado: (2019)

Microbiologic Cure with a Simplified Dosage of Intravenous Colistin in Adults: A Retrospective Cohort Study
por: Al-Zubairy, Sulaiman A
Publicado: (2023)

Bench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
por: Bassetti, Matteo, et al.
Publicado: (2010)

New treatment options against gram-negative organisms
por: Bassetti, Matteo, et al.
Publicado: (2011)

Considerations About Antimicrobial Stewardship in Settings with Epidemic Extended-Spectrum β-Lactamase-Producing or Carbapenem-Resistant Enterobacteriaceae
por: Viale, Pierluigi, et al.
Publicado: (2015)

Treatment of Infections Due to MDR Gram-Negative Bacteria
por: Bassetti, Matteo, et al.
Publicado: (2019)

Challenges in the diagnosis and treatment of candidemia due to multidrug-resistant Candida auris
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

Invasive Candidiasis in Non-Hematological Patients
por: Mikulska, Malgorzata, et al.
Publicado: (2011)

2257. BDG-Guided Management of Empirical Antifungal Therapy: a Real-life Experience in a Hospital-Wide Context with High Incidence of Non-albicans Candida Infection
por: Marconi, Lorenzo, et al.
Publicado: (2019)

Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy
por: Bassetti, Matteo, et al.
Publicado: (2019)

Treatment of Bloodstream Infections Due to Gram-Negative Bacteria with Difficult-to-Treat Resistance
por: Bassetti, Matteo, et al.
Publicado: (2020)

Neutralizing monoclonal antibodies for early treatment of hospital‐acquired SARS‐CoV‐2 infection in hematologic patients
por: Bussini, Linda, et al.
Publicado: (2022)

Predictive model for bacterial co-infection in patients hospitalized for COVID-19: a multicenter observational cohort study
por: Giannella, Maddalena, et al.
Publicado: (2022)

Prognostic Utility of the New Definition of Difficult-to-Treat Resistance Among Patients With Gram-Negative Bloodstream Infections
por: Giannella, Maddalena, et al.
Publicado: (2019)

Cefiderocol treatment for carbapenem-resistant Acinetobacter baumannii infection in the ICU during the COVID-19 pandemic: a multicentre cohort study
por: Pascale, Renato, et al.
Publicado: (2021)

Too many antibiotics for patients with COVID-19 despite low bacterial infections
por: Giacobbe, Daniele Roberto, et al.
Publicado: (2023)

Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19
por: Peghin, Maddalena, et al.
Publicado: (2022)

Inadequate Dosage May Lead to the Recurrence of Postoperative Pulmonary Hypertension in Patients With Congenital Heart Disease
por: Li, Xinmei, et al.
Publicado: (2021)

Screening for carriage of carbapenem-resistant Enterobacteriaceae in settings of high endemicity: a position paper from an Italian working group on CRE infections
por: Ambretti, Simone, et al.
Publicado: (2019)

Liver decompensation predicts ribavirin overexposure in hepatitis C virus patients treated with direct-acting antivirals
por: Guardigni, Viola, et al.
Publicado: (2017)

How to manage KPC infections
por: Bassetti, Matteo, et al.
Publicado: (2020)

147. Non-Fermenting Gram-Negative Bloodstream Infection: A Multicenter Retrospective Cohort Study
por: Pascale, Renato, et al.
Publicado: (2019)

How much European prescribing physicians know about invasive fungal infections management?
por: Valerio, Maricela, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_p73o72umb0v5417uun24o9u5kd